Health X Platform Ltd
- Market cap
- ₹ 822 Cr.
- P/E
- 37.7x
- P/B
- 1.33x
- 52-week range
- 252.5 – 363
- ROE
- 0%
- ROCE
- 0%
- Dividend yield
- 0%
- Debt / equity
- 0.04
- Sector
- Healthcare Services
- Industry
- Healthcare Service Provider
- Listed on
- NSE, BSE
About
Health X Platform Limited, formerly Sastasundar Ventures Limited, is an India-based company, which is engaged in the business of digital networks of healthcare and portfolio management services. The Company's segments include Financial Services and Healthcare Network. The Financial Services segment consists mainly of financing of loans and investment in shares and securities, financial consultancy, professional fees, wealth management, financial planning, distribution, and related services. The Health Network segment includes activities for pathology, food processing and marketing of healthcare and over-the-counter products through e-commerce portal and diagnostic services, which consist of pathological/radiological investigations. Its digital platforms for healthcare include consumer-focused digital healthcare platform consisting of pharmacy, diagnostics and wellness, and a business to business (B2B) digital platform for pharmaceutical and wellness products.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Healthcare Service Provider: 36 companies →Health X Platform Ltd against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)37.7 against a typical 21: pricier than most peers (1st = cheapest).21st of 34
- Sales growth+49.7% against a typical +19.1% from a year earlier.5th of 31
- Profit growth−92.5% against a typical +25.2% from a year earlier.22nd of 24
- Share price, 3 months−8.4% against a typical −7.7%.19th of 33
- Size₹ 822.1 Cr. market value against a typical ₹ 83 Cr. (1st = largest).9th of 34
Board meetings
Results dates and other board meetings. Full calendar
| Details | ||
|---|---|---|
| 7 Aug 2026 | Financial Results | To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended on Jun 30, 2026 |
| 30 May 2026 | Financial Results | To consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended 31st March, 2026. |
| 6 Feb 2026 | Financial Results | To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2025. |
| 13 Nov 2025 | Financial Results | To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2025. |
| 12 Aug 2025 | Financial Results | To consider and approve the Unaudited Standalone and Consolidated financial results for the quarter ended June 30, 2025 |
| 30 May 2025 | Financial Results | To consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended 31st March, 2025 |
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 358 | 375 | 307 | 270 | 274 | 281 | 286 | 298 | 301 | 346 | 374 | 447 |
| Expenses | 355 | 371 | 317 | 273 | 278 | 305 | 311 | 292 | 324 | 356 | 399 | 455 |
| Operating Profit | 3 | 3 | −11 | −2 | −5 | −24 | −25 | 6 | −23 | −10 | −25 | −8 |
| OPM % | 0.9% | 0.9% | −3.5% | −0.9% | −1.7% | −8.4% | −8.8% | 2% | −7.5% | −3% | −6.7% | −1.9% |
| Other Income | 10 | 20 | 18 | 29 | −167 | −14 | 22 | 25 | 5 | 14 | 13 | 13 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Depreciation | 2 | 2 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| Profit before tax | 11 | 21 | 5 | 25 | −174 | −39 | −5 | 30 | −19 | 1 | −15 | 2 |
| Tax % | −23% | 3.9% | −583% | −102.8% | −13.2% | 2% | −478.5% | 11.9% | −17.2% | 59.8% | −12.5% | −0.5% |
| Net Profit | −12 | −3 | 22 | 41 | −155 | −38 | 18 | 27 | −15 | 0 | −13 | 2 |
| EPS in Rs | −2.55 | −0.24 | 5.17 | 9.79 | −34.39 | −8.47 | 4.3 | 7.52 | −3.99 | 0.36 | −3.51 | 0.8 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 31%
- 5 Years
- 19%
- 3 Years
- 8%
- TTM
- 29%
- 10 Years
- 7%
- 5 Years
- 17%
- 3 Years
- 27%
- TTM
- −154%
- 10 Years
- 18%
- 5 Years
- 2%
- 3 Years
- 0%
- TTM
- —
- 10 Years
- −4%
- 5 Years
- −2%
- 3 Years
- 2%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Health X Platform Ltd | ₹ 279.70 | ₹ 822 Cr. | 37.7x | 1.3x | 0% | — |
| Eternal | ₹ 317.00 | ₹ 3,05,916 Cr. | 734.9x | 8.5x | 1.2% | 0.7% |
| Wipro | ₹ 189.75 | ₹ 1,87,946 Cr. | 13.6x | 2.1x | 16.1% | 14% |
| Info Edge (India) | ₹ 1,184.60 | ₹ 76,812 Cr. | 44x | 2x | 4% | 53.7% |
| Tata Technologies | ₹ 656.85 | ₹ 26,672 Cr. | 49.3x | 7.8x | — | 9.4% |
| Netweb Technologies India | ₹ 4,343.00 | ₹ 25,818 Cr. | 116.9x | 33.4x | 32.8% | 9.4% |
Management
- Banwari Lal Mittal
- Executive Chairman of the Board, Chief Executive Officer, Managing Director
- Lokesh Agarwal
- Chief Financial Officer
- Pratap Singh
- Compliance Officer, Company Secretary
Prices are delayed and for information only. Nothing on this page is investment advice.